Dr Stephen A Sevigny, MD - Medicare Diagnostic Radiology in Daytona Beach, FL

Dr Stephen A Sevigny, MD is a medicare enrolled "Radiology - Diagnostic Radiology" physician in Daytona Beach, Florida. He went to University Of Florida College Of Medicine and graduated in 1994 and has 30 years of diverse experience with area of expertise as Diagnostic Radiology. He is a member of the group practice Radiology Imaging Associates, Llc, Inverness Medical Imaging Llc, East Central Florida Outpatient Imaging Llc and his current practice location is 1673 Mason Ave, Suite# 305, Daytona Beach, Florida. You can reach out to his office (for appointments etc.) via phone at (386) 274-7118.

Dr Stephen A Sevigny is licensed to practice in Florida (license number ME0073482) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1326082975.

Contact Information

Dr Stephen A Sevigny, MD
1673 Mason Ave, Suite# 305,
Daytona Beach, FL 32117-5515
(386) 274-7118
(386) 274-6173



Physician's Profile

Full NameDr Stephen A Sevigny
GenderMale
SpecialityDiagnostic Radiology
Experience30 Years
Location1673 Mason Ave, Daytona Beach, Florida
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Stephen A Sevigny attended and graduated from University Of Florida College Of Medicine in 1994
  NPI Data:
  • NPI Number: 1326082975
  • Provider Enumeration Date: 06/15/2006
  • Last Update Date: 07/01/2010
  Medicare PECOS Information:
  • PECOS PAC ID: 9436130341
  • Enrollment ID: I20040526001492

Medical Identifiers

Medical identifiers for Dr Stephen A Sevigny such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1326082975NPI-NPPES
68879OtherFLBLUE CROSS BLUE SHIELD
254118100MedicaidFL

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085N0700XRadiology - Neuroradiology ME0073482 (Florida)Secondary
2085B0100XRadiology - Body Imaging ME0073482 (Florida)Secondary
2085N0904XRadiology - Nuclear Radiology ME0073482 (Florida)Secondary
2085P0229XRadiology - Pediatric Radiology ME0073482 (Florida)Secondary
2085R0202XRadiology - Diagnostic Radiology ME0073482 (Florida)Primary
2085R0203XRadiology - Therapeutic Radiology ME0073482 (Florida)Secondary
2085R0204XRadiology - Vascular & Interventional Radiology ME0073482 (Florida)Secondary
2085U0001XRadiology - Diagnostic Ultrasound ME0073482 (Florida)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Flagler HospitalSaint augustine, FLHospital
Halifax Health Medical CenterDaytona beach, FLHospital
Halifax Health /uf Health Medical Center Of DeltonDeltona, FLHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Radiology Imaging Associates, Llc246634280374
Inverness Medical Imaging Llc387059067266
East Central Florida Outpatient Imaging Llc983017519939

News Archive

Researchers identify sex-specific genetic risk factor for pancreatic cancer

In a new study from Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females.

Royal Philips gets FDA approval for Spectral Breast Density Measurement Application

As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.

Researchers identify a compound that inhibits growth of schwannomas

Schwannomas are tumors of the peripheral nervous system, which often occur in the genetic disease neurofibromatosis type 2. The research group of Prof. Dr. Helen Morrison at the Leibniz Institute on Aging - Fritz Lipmann Institute in Jena, Germany, identified a compound that inhibits the growth of such tumors and improves nerve function.

Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective

Researchers from the US recently compared antibody binding and viral neutralization against 2 SARS-CoV-2 variants that emerged in different parts of the world. The researchers used sera from spike mRNA vaccinated and naturally infected individuals against a circulating B.1 variant and the emerging B.1.351 variant. The study is published on the preprint server bioRxiv.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Stephen A Sevigny allows following entities to bill medicare on his behalf.
Entity NameTimberridge Imaging Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1669460473
PECOS PAC ID: 9436049863
Enrollment ID: O20040318000633

News Archive

Researchers identify sex-specific genetic risk factor for pancreatic cancer

In a new study from Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females.

Royal Philips gets FDA approval for Spectral Breast Density Measurement Application

As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.

Researchers identify a compound that inhibits growth of schwannomas

Schwannomas are tumors of the peripheral nervous system, which often occur in the genetic disease neurofibromatosis type 2. The research group of Prof. Dr. Helen Morrison at the Leibniz Institute on Aging - Fritz Lipmann Institute in Jena, Germany, identified a compound that inhibits the growth of such tumors and improves nerve function.

Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective

Researchers from the US recently compared antibody binding and viral neutralization against 2 SARS-CoV-2 variants that emerged in different parts of the world. The researchers used sera from spike mRNA vaccinated and naturally infected individuals against a circulating B.1 variant and the emerging B.1.351 variant. The study is published on the preprint server bioRxiv.

Read more Medical News

› Verified 1 days ago

Entity NameMedical Imaging Center Of Ocala Llp
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1669469045
PECOS PAC ID: 0345130787
Enrollment ID: O20040318000671

News Archive

Researchers identify sex-specific genetic risk factor for pancreatic cancer

In a new study from Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females.

Royal Philips gets FDA approval for Spectral Breast Density Measurement Application

As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.

Researchers identify a compound that inhibits growth of schwannomas

Schwannomas are tumors of the peripheral nervous system, which often occur in the genetic disease neurofibromatosis type 2. The research group of Prof. Dr. Helen Morrison at the Leibniz Institute on Aging - Fritz Lipmann Institute in Jena, Germany, identified a compound that inhibits the growth of such tumors and improves nerve function.

Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective

Researchers from the US recently compared antibody binding and viral neutralization against 2 SARS-CoV-2 variants that emerged in different parts of the world. The researchers used sera from spike mRNA vaccinated and naturally infected individuals against a circulating B.1 variant and the emerging B.1.351 variant. The study is published on the preprint server bioRxiv.

Read more Medical News

› Verified 1 days ago

Entity NameRadiology Imaging Associates, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1063400729
PECOS PAC ID: 2466342803
Enrollment ID: O20040318000719

News Archive

Researchers identify sex-specific genetic risk factor for pancreatic cancer

In a new study from Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females.

Royal Philips gets FDA approval for Spectral Breast Density Measurement Application

As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.

Researchers identify a compound that inhibits growth of schwannomas

Schwannomas are tumors of the peripheral nervous system, which often occur in the genetic disease neurofibromatosis type 2. The research group of Prof. Dr. Helen Morrison at the Leibniz Institute on Aging - Fritz Lipmann Institute in Jena, Germany, identified a compound that inhibits the growth of such tumors and improves nerve function.

Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective

Researchers from the US recently compared antibody binding and viral neutralization against 2 SARS-CoV-2 variants that emerged in different parts of the world. The researchers used sera from spike mRNA vaccinated and naturally infected individuals against a circulating B.1 variant and the emerging B.1.351 variant. The study is published on the preprint server bioRxiv.

Read more Medical News

› Verified 1 days ago

Entity NameEast Central Florida Outpatient Imaging Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1245271675
PECOS PAC ID: 9830175199
Enrollment ID: O20040628000215

News Archive

Researchers identify sex-specific genetic risk factor for pancreatic cancer

In a new study from Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females.

Royal Philips gets FDA approval for Spectral Breast Density Measurement Application

As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.

Researchers identify a compound that inhibits growth of schwannomas

Schwannomas are tumors of the peripheral nervous system, which often occur in the genetic disease neurofibromatosis type 2. The research group of Prof. Dr. Helen Morrison at the Leibniz Institute on Aging - Fritz Lipmann Institute in Jena, Germany, identified a compound that inhibits the growth of such tumors and improves nerve function.

Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective

Researchers from the US recently compared antibody binding and viral neutralization against 2 SARS-CoV-2 variants that emerged in different parts of the world. The researchers used sera from spike mRNA vaccinated and naturally infected individuals against a circulating B.1 variant and the emerging B.1.351 variant. The study is published on the preprint server bioRxiv.

Read more Medical News

› Verified 1 days ago

Entity NameInverness Medical Imaging Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093763591
PECOS PAC ID: 3870590672
Enrollment ID: O20061108000195

News Archive

Researchers identify sex-specific genetic risk factor for pancreatic cancer

In a new study from Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females.

Royal Philips gets FDA approval for Spectral Breast Density Measurement Application

As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.

Researchers identify a compound that inhibits growth of schwannomas

Schwannomas are tumors of the peripheral nervous system, which often occur in the genetic disease neurofibromatosis type 2. The research group of Prof. Dr. Helen Morrison at the Leibniz Institute on Aging - Fritz Lipmann Institute in Jena, Germany, identified a compound that inhibits the growth of such tumors and improves nerve function.

Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective

Researchers from the US recently compared antibody binding and viral neutralization against 2 SARS-CoV-2 variants that emerged in different parts of the world. The researchers used sera from spike mRNA vaccinated and naturally infected individuals against a circulating B.1 variant and the emerging B.1.351 variant. The study is published on the preprint server bioRxiv.

Read more Medical News

› Verified 1 days ago

Entity NameOcala Health Imaging Services Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023318060
PECOS PAC ID: 8224217179
Enrollment ID: O20110124001037

News Archive

Researchers identify sex-specific genetic risk factor for pancreatic cancer

In a new study from Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females.

Royal Philips gets FDA approval for Spectral Breast Density Measurement Application

As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.

Researchers identify a compound that inhibits growth of schwannomas

Schwannomas are tumors of the peripheral nervous system, which often occur in the genetic disease neurofibromatosis type 2. The research group of Prof. Dr. Helen Morrison at the Leibniz Institute on Aging - Fritz Lipmann Institute in Jena, Germany, identified a compound that inhibits the growth of such tumors and improves nerve function.

Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective

Researchers from the US recently compared antibody binding and viral neutralization against 2 SARS-CoV-2 variants that emerged in different parts of the world. The researchers used sera from spike mRNA vaccinated and naturally infected individuals against a circulating B.1 variant and the emerging B.1.351 variant. The study is published on the preprint server bioRxiv.

Read more Medical News

› Verified 1 days ago

Entity NameSt Thomas Radiology Associates Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1659385011
PECOS PAC ID: 0042235137
Enrollment ID: O20201204000710

News Archive

Researchers identify sex-specific genetic risk factor for pancreatic cancer

In a new study from Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females.

Royal Philips gets FDA approval for Spectral Breast Density Measurement Application

As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.

Researchers identify a compound that inhibits growth of schwannomas

Schwannomas are tumors of the peripheral nervous system, which often occur in the genetic disease neurofibromatosis type 2. The research group of Prof. Dr. Helen Morrison at the Leibniz Institute on Aging - Fritz Lipmann Institute in Jena, Germany, identified a compound that inhibits the growth of such tumors and improves nerve function.

Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective

Researchers from the US recently compared antibody binding and viral neutralization against 2 SARS-CoV-2 variants that emerged in different parts of the world. The researchers used sera from spike mRNA vaccinated and naturally infected individuals against a circulating B.1 variant and the emerging B.1.351 variant. The study is published on the preprint server bioRxiv.

Read more Medical News

› Verified 1 days ago

Entity NameCommunity Imaging Alliance Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1194466854
PECOS PAC ID: 6305227190
Enrollment ID: O20220726001435

News Archive

Researchers identify sex-specific genetic risk factor for pancreatic cancer

In a new study from Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females.

Royal Philips gets FDA approval for Spectral Breast Density Measurement Application

As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.

Researchers identify a compound that inhibits growth of schwannomas

Schwannomas are tumors of the peripheral nervous system, which often occur in the genetic disease neurofibromatosis type 2. The research group of Prof. Dr. Helen Morrison at the Leibniz Institute on Aging - Fritz Lipmann Institute in Jena, Germany, identified a compound that inhibits the growth of such tumors and improves nerve function.

Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective

Researchers from the US recently compared antibody binding and viral neutralization against 2 SARS-CoV-2 variants that emerged in different parts of the world. The researchers used sera from spike mRNA vaccinated and naturally infected individuals against a circulating B.1 variant and the emerging B.1.351 variant. The study is published on the preprint server bioRxiv.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Stephen A Sevigny is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Stephen A Sevigny, MD
1673 Mason Ave, Suite# 305,
Daytona Beach, FL 32117-5515

Ph: (386) 274-7118
Dr Stephen A Sevigny, MD
1673 Mason Ave, Suite# 305,
Daytona Beach, FL 32117-5515

Ph: (386) 274-7118

News Archive

Researchers identify sex-specific genetic risk factor for pancreatic cancer

In a new study from Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females.

Royal Philips gets FDA approval for Spectral Breast Density Measurement Application

As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.

Researchers identify a compound that inhibits growth of schwannomas

Schwannomas are tumors of the peripheral nervous system, which often occur in the genetic disease neurofibromatosis type 2. The research group of Prof. Dr. Helen Morrison at the Leibniz Institute on Aging - Fritz Lipmann Institute in Jena, Germany, identified a compound that inhibits the growth of such tumors and improves nerve function.

Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective

Researchers from the US recently compared antibody binding and viral neutralization against 2 SARS-CoV-2 variants that emerged in different parts of the world. The researchers used sera from spike mRNA vaccinated and naturally infected individuals against a circulating B.1 variant and the emerging B.1.351 variant. The study is published on the preprint server bioRxiv.

Read more News

› Verified 1 days ago


Radiology Doctors in Daytona Beach, FL

Dr. John William Gianini, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 1673 Mason Ave, Suite 305, Daytona Beach, FL 32117
Phone: 386-274-7118    Fax: 386-274-6173
Joseph M Kaminski, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 1620 Mason Ave Ste E, Daytona Beach, FL 32117
Phone: 386-506-5115    Fax: 386-506-5112
Dr. Scott D Klioze, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 1673 Mason Ave, Suite # 305, Daytona Beach, FL 32117
Phone: 386-274-7118    Fax: 386-274-6173
Dr. John E Agles, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 1673 Mason Ave, Suite # 305, Daytona Beach, FL 32117
Phone: 386-274-7118    Fax: 386-274-6173
Dr. John C Tonkin, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 1673 Mason Ave, Suite# 305, Daytona Beach, FL 32117
Phone: 386-274-7118    Fax: 386-274-6173
Dr. David B Turetsky, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 1673 Mason Ave, Suite # 305, Daytona Beach, FL 32117
Phone: 386-274-7118    Fax: 386-274-6173
Dr. Charles David Hechtman, MD, PH.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 303 N Clyde Morris Blvd, Daytona Beach, FL 32114
Phone: 386-254-4210    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.